\
&
Contact us
Published on | 5 years ago
ProgrammesINNO4COV-19 OPEN CALL - Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance
Are you working for a company active in healthcare, medicine, biotech, biopharma, and/or IT-related topics (e.g. robotics, automation, electronics, nanotech, etc)? Then have a look at this accessible funding scheme (up to 100k€ subsidy).
Submission deadlines in November 2020, March 2021 and May 2021.
INNO4COV-19 at a Glance
Create a “lab-to-fab” platform and collaboration resource to enable companies and reference laboratories to develop and implement innovative technologies to fight COVID-19.
Website: www.inno4cov19.eu
The INNO4COV-19 Project aims to support the full development to market uptake of technologies at TRL6-7 or higher. It Provides funding to third parties to archive the desiderated objectives.
Eligibility criteria
What they offer
Key dates
The applications will be considered in three different rounds.
More information on the website of the call: www.inno4cov19.eu/open-call
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Deployment: Best use of technologies
The LDT4SSC (Local Digital Twins for Smart and Sustainable Communities) project has opened a new cascade funding call to local network of cities, regions, and digital innovators. This call supports co-funding for three Work Strands with a minimum available budget of 10.8 Million euros: - Work strand 1 - interconnecting existing LDTs: At least... read more
Professor Inez Germeys leads the Center for Contextual Psychiatry at KU Leuven, which is a large multi-disciplinary research group focusing on the interaction between the person and the environment in the development of psychopathology. She has received a European Research Council (ERC) Consolidator grant (INTERACT) and Proof of Concept grant (IMPACT). With these grants professor Germeys and her team researched a new mobile self-management therapy for patients with a psychotic disorder. The Acceptance and Commitment Therapy in Daily Life (ACT-DL) was further developed for the clinical environment. In line with that the Horizon 2020 IMMERSE project aims to thoroughly evaluate strategies, processes, and outcomes of implementing a digital mobile mental health solution.